Breast Surgical Oncology in Jacksonville

Each year on average, more than 600 people undergo breast surgery at Mayo Clinic in Florida. This high-volume clinical practice fosters expertise among our surgeons and care teams.

Recognized expertise

Mayo breast surgeons are recognized for their high-volume performance of complex procedures with excellent outcomes.

Your Mayo Clinic physicians are established national leaders, widely recognized in their fields.

Outside organizations recognize Mayo Clinic breast cancer surgeons through accreditations, grants and rankings:

• Mayo Clinic Comprehensive Cancer Center meets the strict standards for a National Cancer Institute comprehensive cancer center, which recognizes scientific excellence and a multispecialty approach focused on cancer prevention, diagnosis and treatment.
• Mayo Clinic is one of a select group of medical centers in the United States to be recognized as a Specialized Program of Research Excellence (SPORE) for breast cancer research, funded by the National Cancer Institute. To earn a highly competitive SPORE grant, institutions must demonstrate a high degree of collaboration between first-rate scientists and clinicians and show excellence in translational research projects.

We train surgeons: Top-ranked education program

• The General Surgery Residency program at Mayo Clinic College of Medicine has received the maximum five-year ACGME accreditation every cycle since its inception.
• Breast surgeons serve within the medical school program, educating and training future physicians in the latest surgical approaches to care.

Learn more about Mayo Clinic's quality rankings.

Translational research expertise

Our breast surgeons collaborate with scientists in Mayo Clinic's research facilities to develop innovative solutions for patients, rapidly leveraging research insights into clinical practice.

People who come to Mayo Clinic are frequently among the first to benefit from innovative therapies, new techniques and technology, and clinical research trials. Our team is engaged in research trials for people with invasive cancer and ductal carcinoma in situ (DCIS), as well as those at increased risk of future breast cancer.

自 1990 年《美国新闻与世界报道》开始发布排名起，妙佑医疗国际就一直被评为顶级癌症医院。在《美国新闻与世界报道》最新发布的 2023–2024 年全美顶级癌症医院评选中，妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际佛罗里达州杰克逊维尔院区和妙佑医疗国际亚利桑那州凤凰城/斯科茨代尔院区均名列前茅。